PUR Share Price Performance
zł2.41
-6.69 (-73.52%)
Price zł2.41
Share Pricen/a
Pure Biologics S.A. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
PUR Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
Pure Biologics S.A. Key Details
Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
May 15, 2026
- -1.03
- 0%
- 0%
- -77.2%
About PUR
- Founded
- 2010
- Employees
- 6
- CEO
- WebsiteView website
Pure Biologics S.A., a biopharmaceutical company, engages in the research and development of biological drugs and medical devices for therapeutic use. Its therapeutic portfolio in the field of immuno-oncology includes PB003G, which targets the GARP-TGFß1 complex; PB004, an anticancer drug based on an anti-ROR1 antibody; and PB003A, a therapy that targets the aVß8 integrin. The company was founded in 2010 and is based in Wroclaw, Poland.
